Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52

James N. Ingle, Vera J. Suman, James A. Mailliard, John W. Kugler, James E. Krook, John C. Michalak, Thomas M. Pisansky, Lester E. Wold, John H. Donohue, Matthew P. Goetz, Edith A. Perez

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52'. Together they form a unique fingerprint.

Medicine & Life Sciences